HIV and COVID-19 – What We’ve Learned

IDSA CEO Jeanne Marrazzo, MD, MPH, FIDSA, sits down with Past President, Daniel McQuillen, MD, FIDSA, and private practice infectious diseases physician, Sneha Thatipelli, MD, to discuss the value of volunteering with IDSA, finding the right opportunity and how getting involved c ...  Show more

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA is joined by IDSA Senior Vice President of Public Policy and Government Relations Amanda Jezek to discuss the policy challenges shaping infectious diseases, public health and research ahead of the midterm elections. They explore IDSA's a ...  Show more

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Show more

For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company Americ ...  Show more

Three members of President Biden's former COVID-19 Advisory Board—Luciana Borio, MD, Ezekiel Emanuel, MD, PhD, and Mike Osterholm, PhD—discuss their recent JAMA Viewpoints, providing their ideas on strategies for public health as COVID-19 transitions from pandemic to endemic. ...

In this episode I cover HIV.

If you want to follow along with written notes on HIV go to https://zerotofinals.com/medicine/infectiousdisease/hiv/ or the infectious diseases section in the Zero to F ...